14 In Spain, although the rates of erythromycin resistance have decreased in SAUCE (Susceptibility to the Antimicrobials Used in the Community in España) studies over recent years (26.7% in 1996–1997, 20.4% in 1998–1999, 24.3% in 2001–2002, and 19.0% in 2006–2007), no temporal decreasing trend for erythromycin resistance was found in contrast to an increasing trend in the percentage of the MLS B phenotype (7.0%, 10.5%, 14.0%, and 35.5%, respectively, among resistant strains in the corresponding SAUCE studies). 15 Since both mechanisms of resistance (M-efflux and MLS B ) imply resistance to 14- and 15-membered macrolides, erythromycin resistance implies resistance to azithromycin and clarithromycin. 16 H. influenzae Resistance to β-lactams in H. influenzae is defined using ampicillin as a marker of resistance.
← all excerpts
Cefditoren in upper and lower community-acquired respiratory tract infections.
2
—
—
The sentences
29 , 30 The SAUCE studies in Spain (1996–1997, 1998–1999, 2001–2002, 2006–2007) have shown a decreasing trend for penicillin nonsusceptibility rates (60.0%, 50.2%, 43.9%, and 22.9%, respectively) in contrast to erythromycin nonsusceptibility, which has shown lower variations (36.5%, 34.9%, 34.5%, and 22.9%, respectively), the MLS B resistance phenotype decreasing over time (from 98.4% in 1996–1997 to 81.3% in 2006–2007).